Home > News > Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
January 9th, 2007
Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
Mirus Bio Corporation announced today it has entered into a two year, multimillion dollar agreement with Pfizer Inc. to investigate and optimize gene silencing methods in animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to target and suppress the expression of genes of interest to Pfizer.
Nanometrics to Participate in the 8th Annual CEO Investor Summit: Investor Event Held Concurrently with SEMICON West 2016 in San Francisco June 22nd, 2016
Artificial synapse rivals biological ones in energy consumption June 21st, 2016
NanoLabNL boosts quality of research facilities as Dutch Toekomstfonds invests firmly June 10th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016
A drop of water as a model for the interplay of adhesion and stiction June 30th, 2016
No need in supercomputers: Russian scientists suggest a PC to solve complex problems tens of times faster than with massive supercomputers June 30th, 2016
Surprising qualities of insulator ring surfaces: Surface phenomena in ring-shaped topological insulators are just as controllable as those in spheres made of the same material June 30th, 2016
How cancer cells spread and squeeze through tiny blood vessels (video) June 30th, 2016